Charles Explorer logo
🇬🇧

The Nebivolol

Publication at First Faculty of Medicine, Third Faculty of Medicine |
2012

Abstract

Nebivolol is highly cardioselective beta-blocker, suitable for the treatment of hypetenssion and coronary artery disease.